Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 3Immunoblastic Lymphadenopathy 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Hodgkin Disease 2Sezary Syndrome 1Recurrence 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia 1Bronchiolitis Obliterans Syndrome 1Anemia, Aplastic 1

Interventions

Psychiatric Rehabilitation 2romidepsin 1motesanib diphosphate 1fludarabine phosphate 1carbendazim 1Ultraviolet Therapy 1Therapeutics 1Standard of Care 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Methoxsalen 1Melphalan 1Levofloxacin 1Lenalidomide 1Ketamine 1Interleukin-12 Subunit p35 1Indinavir 1Gemcitabine 1Flow Cytometry 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Ciprofloxacin 1Cefepime 1Bexarotene 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Sezary Syndrome × Alemtuzumab × Clear all
NCT00157274 2007-04-03

Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

Latin American Cooperative Onco-Haematology Group - Peru

Phase 2 Unknown
20 enrolled
Lymphoid

Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡